TP53 mutated AML subclones exhibit engraftment in a humanized bone marrow ossicle mouse model

被引：5
|
作者：
Pabst, Gabriel [1 ]
Lind, Karin [1 ]
Graf, Ricarda [2 ]
Zebisch, Armin [1 ,3 ]
Stoelzel, Friedrich [4 ]
Doehner, Konstanze [5 ]
Heitzer, Ellen [2 ]
Reinisch, Andreas [1 ]
Sill, Heinz [1 ]
机构：
[1] Med Univ Graz, Div Hematol, Dept Internal Med, Auenbruggerpl 38, A-8036 Graz, Austria
[2] Med Univ Graz, Inst Human Genet, Graz, Austria
[3] Med Univ Graz, Otto Loewi Res Ctr Vasc Biol Immunol & Inflammat, Div Pharmacol, Graz, Austria
[4] Dresden Univ Technol Dresden, Dept Internal Med 1, Univ Hosp Carl Gustav Carus, Dresden, Germany
[5] Univ Hosp Ulm, Dept Internal Med 3, Ulm, Germany
来源：
ANNALS OF HEMATOLOGY | 2020年 / 99卷 / 03期
基金：
奥地利科学基金会;
关键词：
STEM-CELLS; MUTATIONS; XENOTRANSPLANTATION; GENERATION; EVOLUTION; ORIGIN;
D O I：
10.1007/s00277-020-03920-y
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：653 / 655
页数：3
相关论文
共 50 条
  • [31] Early TP53 alterations engage environmental exposures to promote gastric premalignancy in an integrative mouse model
    Nilay S. Sethi
    Osamu Kikuchi
    Gina N. Duronio
    Matthew D. Stachler
    James M. McFarland
    Ruben Ferrer-Luna
    Yanxi Zhang
    Chunyang Bao
    Roderick Bronson
    Deepa Patil
    Francisco Sanchez-Vega
    Jie-Bin Liu
    Ewa Sicinska
    Jean-Bernard Lazaro
    Keith L. Ligon
    Rameen Beroukhim
    Adam J. Bass
    Nature Genetics, 2020, 52 : 219 - 230
  • [32] p53 protein overexpression in bone marrow biopsies from chronic lymphocytic leukaemia is associated with TP53 deletion and resistance to fludarabine
    Martin P.
    Attygalle A.D.
    Swansbury J.
    Min T.
    Morilla A.
    Hockley S.L.
    Wotherspoon A.
    Morgan G.J.
    Catovsky D.
    Dearden C.E.
    Matutes E.
    Journal of Hematopathology, 2010, 3 (2-3) : 61 - 68
  • [33] An African-specific polymorphism in the TP53 gene impairs p53 tumor suppressor function in a mouse model
    Jennis, Matthew
    Kung, Che-Pei
    Basu, Subhasree
    Budina-Kolomets, Anna
    Leu, Julia I-Ju
    Khaku, Sakina
    Scott, Jeremy P.
    Cai, Kathy Q.
    Campbell, Michelle R.
    Porter, Devin K.
    Wang, Xuting
    Bell, Douglas A.
    Li, Xiaoxian
    Garlick, David S.
    Liu, Qin
    Hollstein, Monica
    George, Donna L.
    Murphy, Maureen E.
    GENES & DEVELOPMENT, 2016, 30 (08) : 918 - 930
  • [34] ADAMTS13 accelerates the cell engraftment efficacy in mouse model of bone marrow transplantation
    Matsui, H.
    Doi, M.
    Matsunari, Y.
    Takeda, M.
    Nishio, K.
    Shima, M.
    Soejima, K.
    Banno, F.
    Miyata, T.
    Sugimoto, M.
    JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2013, 11 : 458 - 458
  • [35] ADAMTS13 Improving the Cell Engraftment Efficacy in Mouse Model of Bone Marrow Transplantation
    Matsui, Hideto
    Doi, Masaaki
    Matsunari, Yasunori
    Takeda, Maiko
    Nishio, Kenji
    Shima, Midori
    Soejima, Kenji
    Banno, Fumiaki
    Akiyama, Masashi
    Kokame, Koichi
    Miyata, Toshiyuki
    Sugimoto, Mitsuhiko
    BLOOD, 2012, 120 (21)
  • [36] Humanized Bone Marrow Mouse Model as a Preclinical Tool to Assess Therapy-Mediated Hematotoxicity
    Cai, Shanbao
    Wang, Haiyan
    Bailey, Barbara
    Ernstberger, Aaron
    Juliar, Beth E.
    Sinn, Anthony L.
    Chan, Rebecca J.
    Jones, David R.
    Mayo, Lindsey D.
    Baluyut, Arthur R.
    Goebel, W. Scott
    Pollok, Karen E.
    CLINICAL CANCER RESEARCH, 2011, 17 (08) : 2195 - 2206
  • [37] 131I-Apamistamab-Led Allogeneic Hematopoietic Cell Transplant Significantly Improves Overall Survival in Patients with TP53 Mutated R/R AML
    Choe, Hannah
    Tomlinson, Ben K.
    Gyurkocza, Boglarka
    Nath, Rajneesh
    Seropian, Stuart
    Litzow, Mark R.
    Abboud, Camille N.
    Stiff, Patrick J.
    Abhyankar, Sunil
    Foran, James M.
    Abedin, Sameem
    Chen, George
    Al-Kadhimi, Zaid
    Kebriaei, Partow
    Sabloff, Mitchell
    Orozco, Johnnie J.
    Jamieson, Katarzyna Joanna
    Magalhaes-Silverman, Margarida
    Van Besien, Koen
    Schuster, Michael W.
    Law, Arjun D.
    Mayer, Sebastian A.
    Lazarus, Hillard M.
    Spross, Jennifer
    Li, Kate L.
    Haeuber, Elaina
    Vusirikala, Madhuri
    Nahar, Akash
    Sandmaier, Brenda M.
    Pagel, John
    Giralt, Sergio A.
    Desai, Avinash
    Koshy, Nebu
    BLOOD, 2023, 142
  • [38] APR 246 PLUS AZACITIDINE (AZA) IN TP53 MUTATED (M) MDS AND AML. LONG TERM FOLLOW UP OF PHASE 2 STUDY BY THE GFM
    Cluzeau, T.
    Sebert, M.
    Rahme, R.
    Cuzzubbo, S.
    Walter-Petrich, A.
    Peterlin, P.
    Recher, C.
    Stamatoullas, A.
    Willems, L.
    Raffoux, E.
    Berthon, C.
    Sallman, D.
    Ades, L.
    Fenaux, P.
    LEUKEMIA RESEARCH, 2021, 108 : S17 - S17
  • [39] Bone Marrow Fibrosis at Diagnosis and during the Course of Disease Is Associated with TP53 Mutations and Adverse Prognosis in Primary Myelodysplastic Syndrome
    Zhao, Youshan
    Guo, Juan
    Zhao, Sida
    Wang, Roujia
    Shi, Lei
    Fang, Ying
    Zhang, Zheng
    Song, Luxi
    Wu, Dong
    Chang, Chunkang
    CANCERS, 2022, 14 (12)
  • [40] Gα13 loss in Kras/Tp53 mouse model of pancreatic tumorigenesis promotes tumors susceptible to rapamycin
    Shields, Mario A.
    Spaulding, Christina
    Metropulos, Anastasia E.
    Khalafalla, Mahmoud G.
    Pham, Thao N. D.
    Munshi, Hidayatullah G.
    CELL REPORTS, 2022, 38 (09):
12345